Mechanisms of Signal Transduction Utilized by Growth Hormone

The Somatotrophic Axis in Brain Function

Volumn , Issue , 2006, Pages 39-49

  Shafiei, Farhad ^a   Herington, Adrian C ^b   Lobie, Peter E ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882528456     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088484-1/50006-9     Document Type: Chapter

References (116)

1. Adams T.E., Hansen J.A., Starr R., Nicola N.A., Hilton D.J., Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem. 1998, 273:1285-1287.
2. Argetsinger L.S., Campbell G.S., Yang X., Witthuhn B.A., Silvennoinen O., Ihle J.N., Carter-Su C. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 1993, 74:237-244.
3. Barton D.E., Foellmer B.E., Wood W.I., Francke U. Chromosome mapping of the growth hormone receptor gene in man and mouse. Cytogenet. Cell. Genet. 1989, 50:137-141.
4. Baumbach W.R., Horner D.L., Logan J.S. The growth hormone-binding protien in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes. Dev. 1989, 3:1199-1205.
5. Bazan J.F. A novel family of growth factor receptors: A common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem. Biophys. Res. Commun. 1989, 164:788-795.
6. Cary L.A., Guan J.L. Focal adhesion kinase in integrin-mediated signaling. Front. Biosci. 1999, 4:D102-D113.
7. Chen H.C., Guan J.L. Stimulation of phosphatidylinositol 3′-kinase association with focal adhesion kinase by platelet-derived growth factor. J. Biol. Chem. 1994, 269:31223-31229.
8. Chin H., Arai A., Wakao H., Kamiyama R., Miyasaka N., Miura O. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Blood 1998, 91:3734-3745.
9. Clackson T., Ultsch M.H., Wells J.A., De Vos A.M. Structural and functional analysis of the 1:1 growth hormone receptor complex reveals the molecular basis for receptor affinity. J. Mol. Biol. 1998, 277:1111-1128.
10. Cosman D., Lyman S.D., Idzerda R.L., Beckmann M.P., Park L.S., Goodwin R.G., March C.J. A new cytokine receptor superfamily. Trends Biochem. Sci. 1990, 15:265-270.
11. Dastot F., Sobrier M.L., Duquesnoy P., Duriez B., Goossens M., Amselem S. Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein. Proc. Natl. Acad. Sci. USA 1996, 93:10723-10728.
12. Denson L.A., Held M.A., Menon R.K. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284:G646-G654.
13. De Vos A.M., Ultsch M., Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 1992, 255:306-312.
14. Dhe-Paganon S., Werner E.D., Nishi M., Hansen L., Chi YI., Shoelson S.E. A phenylalanine zipper mediates APS dimerization. Nature Struct. Mol. Biol. 2004, 11:968-974.
15. Diakonova M., Gunter D.R., Herrington J., Carter-Su C. SH2-Bbeta is a Rac-binding protein that regulates cell motility. J. Biol. Chem. 2002, 277:10669-10677.
16. Dinerstein H., Lago F., Goujon L., Ferrag F., Esposito N., Finidori J., Kelly P.A., Postel-Vinay M.C. The proline-rich region of the GH receptor is essential for JAK2 phosphorylation, activation of cell proliferation, and gene transcription. Mol. Endocrinol. 1995, 9:1701-1707.
17. Dominici F.P., Turyn D. Growth hormone-induced alterations in the insulin-signaling system. Exp. Biol. Med. 2002, 227:149-157.
18. Endo K., Takeshita T., Kasai H., Sasaki Y., Tanaka N., Asao H., Kikuchi K., Yamada M., Chenb M., O'Shea J.J., Sugamura K. STAM2, a new member of the STAM family, binding to the Janus kinases. FEBS Lett. 2000, 477:55-61.
19. Favre H., Benhamou A., Finidori J., Kelly P.A., Edery M. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Lett. 1999, 453:63-66.
20. Finidori J. Regulators of growth hormone signaling. Vitam. Horm. 2000, 59:71-97.
21. Fleenor D.E., Freemark M. Prolactin induction of insulin gene transcription: Roles of glucose and signal transducer and activator of transcription 5. Endocrinology 2001, 142:2805-2810.
22. Foster C.M., Shafer J.A., Rozsa F.W., Wang X., Lewis S.D., Renken D.A., Natale J.E., Schwartz J., Carter-Su C. Growth hormone promoted tyrosyl phosphorylation of growth hormone receptors in murine 3T3-F442A fibroblasts and adipocytes. Biochemistry 1998, 27:326-334.
23. Frank S.J., Yi W., Zhao Y., Goldsmith J.F., Gilliland G., Jiang J., Sakai I., Kraft A.S. Regions of the JAK2 tyrosine kinase reuired for coupling to the growth hormone receptor. J. Biol. Chem. 1995, 270:14776-14785.
24. Friedrichsen B.N., Galsgaard E.D., Nielsen J.H., Moldrup A. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5). Mol. Endocrinol. 2001, 15:136-148.
25. Goh E.L., Pircher T.J., Wood T.J., Norstedt G., Graichen R., Lobie P.E. Growth hormone-induced reorganization of the actin cytoskeleton is not required for STAT5 (signal transducer and activator of transcription-5)-mediated transcription. Endocrinology 1997, 138:3207-3215.
26. Goh E.L., Zhu T., Leong W.Y., Lobie P.E. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription. Endocrinology 2002, 143:3590-3603.
27. Goi T., Shipitsin M., Lu Z., Foster D.A., Klinz S.G., Feig L.A. An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity. EMBO J. 2000, 19:623-630.
28. Gotoh T., Hattori S., Nakamura S., Kitayama H., Noda M., Takai Y., Kaibuchi K., Matsui H., Hatase O., Takahashi H., Kurata T., Matsuda M. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol. 1995, 15:6746-6753.
29. Goujon L., Allevato G., Simonin G., Paquereau L., Le Cam A., Clark J., Nielsen J.H., Djiane J., Postel-Vinay M.C., Edery M., Kelly P.A. Cytoplasmic sequences of the growth hormone receptor necessary for signal transduction. Proc. Natl. Acad. Sci. USA 1994, 91:957-961.
30. Graichen R., Sandstedt J., Goh E.L., Isaksson O.G., Tornell J., Lobie P.E. The growth hormone-binding protein is a location-dependent cytokine receptor transcriptional enhancer. J. Biol. Chem. 2003, 278:6346-6354.
31. Greenhalgh C.J., Alexander W.S. Suppressors of cytokine signaling and regulation of growth hormone action. Growth Horm. IGF. Res. 2004, 14:200-206.
32. Greenhalgh C.J., Bertolino P., Asa S.L., Metcalf D., Corbin J.E., Adams T.E., Davey H.W., Nicola N.A., Hilton D.J., Alexander W.S. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol. Endocrinol. 2002, 16:1394-1406.
33. Greenhalgh C.J., Metcalf D., Thaus A.L., Corbin J.E., Uren R., Morgan P.O., Fabri L.J., Zhang J.G., Martin H.M., Willson T.A., Billestrup N., Nicola N.A., Baca M., Alexander W.S., Hilton D.J. Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. J. Biol. Chem. 2002, 277:40181-40184.
34. Gu Y., Zou Y., Aikawa R., Hayashi D., Kudoh S., Yamauchi T., Uozumi H., Zhu W., Kadowaki T., Yazaki Y., Komuro I. Growth hormone signalling and apoptosis in neonatal rat cardiomyocytes. Mol. Cell. Biochem. 2001, 223:35-46.
35. Guan J.L., Chen H.C. Signal transduction in cell-matrix interactions. Int. Rev. Cytol. 1996, 168:81-121.
36. Hackett R.H., Wang Y.D., Sweitzer S., Feldman G., Wood W.I., Larner A.C. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins. J. Biol. Chem. 1997, 272:11128-11132.
37. Hansen J.A., Lindberg K., Hilton D.J., Nielsen J.H., Billestrup N. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. Mol. Endocrinol. 1999, 13:1832-1843.
38. Herington A.C. Growth hormone binding proteins and their relationship to the growth hormone receptor. Endocrinol. Metab. 1994, 1(Suppl, A):9-15.
39. Herington A.C., Ymer S.I., Stevenson J.L. Identification and characterization of specific binding proteins for hGH in normal human serum. J. Clin. Invest. 1986, 77:1817-1823.
40. Herrington J., Smit L.S., Schwartz J., Carter-Su C. The role of STAT proteins in growth hormone signaling. Oncogene 2000, 19:2585-2597.
41. Hilton D.J., Richardson R.T., Alexander W.S., Viney E.M., Willson T.A., Sprigg N.S., Starr R., Nicholson S.E., Metcalf D., Nicola N.A. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 1998, 95:114-119.
42. Ihle J.N., Witthuhn B.A., Quelle F.W., Yamamoto K., Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 1995, 13:369-398.
43. Jiang H., Luo J.Q., Urano T., Frankel P., Lu Z., Foster D.A., Feig L.A. Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 1995, 378:409-412.
44. Johnston J.A., Kawamura A.M., Kirken R.A., Chen Y.Q., Blake T.B., Shibuya K., Ortaldo J.R., McVicar D.W., O'Shea J.J. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 1994, 370:151-153.
45. Kile B.T., Schulman B.A., Alexander W.S., Nicola N.A., Martin H.M., Hilton D.J. The SOCS box: A tale of destruction and degradation. Trends Biochem. Sci. 2002, 27:235-241.
46. Kim S.O., Jiang J., Yi W., Feng G.S., Frank S.J. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling. J. Biol. Chem. 1998, 273:2344-2354.
47. Kiosses W.B., Daniels R.H., Otey C., Bokoch G.M., Schwartz M.A. A role for p21-activated kinase in endothelial cell migration. J. Cell. Biol. 1999, 147:831-844.
48. Kiyokawa E., Hashimoto Y., Kobayashi S., Sugimura H., Kurata T., Matsuda M. Activation of Rac1 by a Crk SH3-binding protein, DOCK180. Genes Dev. 1998, 12:3331-3336.
49. Leung K.C., Doyle N., Ballesteros M., Sjogren K., Watts C.K.W., Low T.H., Leong G.M., Ross R.J.M., Ho K.K.Y. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc. Natl. Acad. Sci. USA 2003, 100:1016-1021.
50. Liang L., Zhou T., Jiang J., Pierce J.H., Gustafson T.A., Frank S.J. Insulin receptor substrate-1 enhances growth hormone-induced proliferation. Endocrinology 1999, 140:1972-1983.
51. Ling L., Jiang J., Frank S.J. Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation. Endocrinology 2000, 141:3328-3336.
52. Ling L., Lobie P.E. RhoA/ROCK activation by growth hormone abrogates p300/histone deacetylase 6 repression of Stat5-mediated transcription. J. Biol. Chem. 2004, 279:32737-32750.
53. Ling L., Zhu T., Lobie P.E. Src-CrkII-C3G-dependent activation of Rap1 switches growth hormone-stimulated p44/42 MAP kinase and JNK/SAPK activities. J. Biol. Chem. 2003, 278:27301-27311.
54. Liu K.D., Gaffen S.L., Goldsmith M.A. JAK/STAT signaling by cytokine receptors. Curr. Opin. Immunol. 1998, 10:271-278.
55. Luo J.Q., Liu X., Frankel P., Rotunda T., Ramos M., Flom J., Jiang H., Feig L.A., Morris A.J., Kahn R.A., Foster D.A. Functional association between Arf and RalA in active phospholipase D complex. Proc. Natl. Acad. Sci. USA 1998, 95:3632-3637.
56. Matsuda M., Tanaka S., Nagata S., Kojima A., Kurata T., Shibuya M. Two species of human CRK cDNA encode proteins with distinct biological activities. Mol. Cell. Biol. 1992, 12:3482-3489.
57. Metcalf D., Greenhalgh C.J., Viney E., Willson T.A., Starr R., Nicola N.A., Hilton D.J., Alexander W.S. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 2000, 405:1069-1073.
58. Miller M.E., Michaylira C.Z., Simmons J.G., Ney D.M., Dahly E.M., Heath J.K., Lund P.K. Suppressor of cytokine signaling-2: A growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology 2004, 127:570-581.
59. Moutoussamy S., Renaudie F., Lago F., Kelly P.A., Finidori J. Grb10 identified as a potential regulator of growth hormone (GH) signaling by cloning of GH receptor target proteins. J. Biol. Chem. 1998, 273:15906-15912.
60. Mukhina S., Mertani H.C., Guo K., Lee K.O., Gluckman P.D., Lobie P.E. Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. Proc. Natl. Acad. Sci. USA 2004, 101:15166-15171.
61. Nicola N.A., Greenhalgh C.J. The suppressors of cytokine signaling (SOCS) proteins: Important feedback inhibitors of cytokine action. Exp. Hematol. 2000, 28:1105-1112.
62. Ohba Y., Mochizuki N., Matsuo K., Yamashita S., Nakaya M., Hashimoto Y., Hamaguchi M., Kurata T., Nagashima K., Matsuda M. Rap2 as a slowly responding molecular switch in the Rap1 signaling cascade. Mol. Cell. Biol. 2000, 20:6074-6083.
63. Pandey P., Avraham S., Kumar S., Nakazawa A., Place A., Ghanem L., Rana A., Kumar V., Majumder P.K., Avraham H., Davis R.J., Kharbanda S. Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism. J. Biol. Chem. 1999, 274:10140-10144.
64. Patthy L. Homology of a domain of the growth hormone/prolactin receptor family with type III modules of fibronectin. Cell 1990, 61:13-14.
65. Ram P.A., Waxman D.J. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J. Biol. Chem. 1997, 272:17694-177702.
66. Ram P.A., Waxman D.J. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J. Biol. Chem. 1999, 274:35553-35561.
67. Ram P.A., Waxman D.J. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone. J. Biol. Chem. 2000, 275:39487-39496.
68. Reddy E.P., Korapati A., Chaturvedi P., Rane S. IL-3 signaling and the role of Src kinases, JAKs and STATs: A covert liaison unveiled. Oncogene 2000, 19:2532-2547.
69. Ridderstrale M., Degerman E., Tornqvist H. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. J. Biol. Chem. 1995, 279:3471-3474.
70. Ridderstrale M., Tornqvist H. PI-3-kinase inhibitor wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 1994, 203:306-310.
71. Ross R.J., Esposito N., Shen X.Y., VonLaue S., Chew S.L., Dobson P.R., Postel-Vinay M.C., Finidori J. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol. Endocrimol. 1997, 11:265-273.
72. Rui L., Gunter D.R., Herrington J., Carter-Su C. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-Bbeta. Mol. Cell. Biol. 2000, 20:3168-3177.
73. Rui L., Mathews L.S., Hotta K., Gustafson T.A., Carter-Su C. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Mol. Cell. Biol. 1997, 17:6633-6644.
74. Ryu H., Lee J.H., Kim K.S., Jeong S.M., Kim P.H., Chung H.T. Regulation of neutrophil adhesion by pituitary growth hormone accompanies tyrosine phosphorylation of Jak2, p125FAK, and paxillin. J. Immunol. 2000, 165:2116-2123.
75. Saharinen P., Takaluoma K., Silvennoinen O. Regulation of the Jak2 tyrosine kinase by its pseudokinase domain. Mol. Cell. Biol. 2000, 20:3387-3395.
76. Schlaepfer D.D., Hunter T. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src. J. Biol. Chem. 1997, 272:13189-13195.
77. Schlaepfer D.D., Hunter T. Integrin signaling and tyrosine phosphorylation: Just the FAKs?. Trends Cell Biol. 1998, 8:151-157.
78. Sells M.A., Boyd J.T., Chernoff J. p21-activated kinase 1 (Pak1) regulates cell motility in mammalian fibroblasts. J. Cell Biol. 1999, 145:837-849.
79. Shigematsu H., Iwasaki H., Otsuka T., Ohno Y., Arima F., Niho Y. Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activity. J. Biol. Chem. 1997, 272:14334-14340.
80. Shuai K. The STAT family of proteins in cytokine signaling. Prog. Biophys. Mol. Biol. 1999, 71:405-422.
81. Smit L.S., Meyer D.J., Billestrup N., Norstedt G., Schwartz J., Carter-Su C. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Mol. Endocrinol. 1996, 10:519-533.
82. Sotiropoulos A., Goujon L., Simonin G., Kelly P.A., Postel-Vinay M.C., Finidori J. Evidence for the generation of the growth hormone binding protein through proteolysis of the growth hormone membrane receptor. Endocrinology 1993, 132:1863-1865.
83. Sotiropoulos A., Moutoussamy S., Renaudie F., Clauss M., Kayser C., Gouilleux F., Kelly P.A., Finidori J. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Mol. Endocrinol. 1996, 10:998-1009.
84. Souza S.C., Frick G.P., Wang X., Kopchick J.K., Lobo R.B., Goodman H.M. A single arginine residue determines species specificity of the human growth hormone receptor. Proc. Natl. Acad. Sci. USA 1995, 92:959-963.
85. Souza S.C., Frick G.P., Yip R., Lobo R.B., Tai L.R., Goodman H.M. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 1994, 269:30085-30088.
86. Starr R., Metcalf D., Elefanty A.G., Brysha M., Willson T.A., Nicola N.A., Hilton D.J., Alexander W.S. Liver degeneration and lymphoid deficencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 1998, 95:14395-14399.
87. Stofega M.R., Wang H., Ullrich A., Carter-Su C. Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association. J. Biol. Chem. 1998, 273:7112-7117.
88. Stofega M.R., Herrington J., Billestrup N., Carter-Su C. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B. Mol. Endocrinol. 2000, 14:1338-1350.
89. Takahashi M.O., Takahashi Y., Iida K., Okimura Y., Kaji H., Abe H., Chihara K. Growth hormone stimulates tyrosine phosphorylation of focal adhesion kinase (p125(FAK)) and actin stress fiber formation in human osteoblast-like cells, Saos2. Biochem. Biophys. Res. Commun. 1999, 263:100-106.
90. Takahashi-Tezuka M., Hibi M., Fujitani Y., Fukuda T., Yamaguchi T., Hirano T. Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK. Oncogene 1997, 14:2273-2282.
91. Takai Y., Sasaki T., Matozaki T. Small GTP-binding proteins. Physiol. Rev. 2001, 81:153-208.
92. Takeshita T., Arita T., Higuchi M., Asao H., Endo K., Kuroda H., Tanaka N., Murata K., Ishii N., Sugamura K. STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity 1997, 6:449-457.
93. Tanaka S., Amling M., Neff L., Peyman A., Uhlmann E., Levy J.B., Baron R. c-Cbl is downstream of c-Src in a signaling pathway necessary for bone resorption. Nature 1996, 383:528-531.
94. Tanner J.W., Chen W., Young R.L., Longmore G.D., Shaw A.S. The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J. Biol. Chem. 1995, 270:6523-6530.
95. Turnley A.M., Faux C.H, Rietze R.L., Coonan J.R., Bartlett P.F. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling. Nature Neurosci. 2002, 5:1155-1162.
96. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.H., Ram P.A., Waxman D.J., Davey H.W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 1997, 94:7239-7244.
97. VanderKuur J., Wang X., Zhang L-Y., Campbell G., Billestrup N., Norstedt G., Carter-Su C. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase. J. Biol. Chem. 1994, 269:21709-21717.
98. VanderKuur J.A., Allevato G., Billestrup N., Norstedt G., Carter-Su C. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor. J. Biol. Chem. 1995, 270:7587-7593.
99. VanderKuur J.A., Butch E.R., Waters S.B., Pessin J.E., Guan K.L., Carter-Su C., Wang P., Li N., Li J.S. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation. Endocrinology. Acta Pharmacol. Sin. 2002, 23:16-22.
100. Wang P., Li N., Li J.S., Li W.Q. The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity. World J. Gastroenterol. 2002, 8:531-536.
101. Wang X., He K., Gerhart M., Huang Y., Huang Y., Jiang J., Paxton R.J., Yang S., Lu C., Menon R.K., Black R.A., Baumann G., Frank S.J. Metalloprotease-mediated GH receptor proteolysis and GHBP shedding: Determination of extracellular domain stem region cleavage site. J. Biol. Chem. 2002, 277:50510-50519.
102. Waters M.J. The growth hormone receptor. The Handbook of Physiology 1997, Vol. 5:1301-1348. Oxford Univ. Press, Oxford. J.L. Kostyo (Ed.).
103. Wells J.A. Binding in the growth hormone receptor complex. Proc. Natl. Acad. Sci. USA 1996, 93:1-6.
104. Winston L.A., Hunter T. JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J. Biol. Chem. 1995, 270:30837-30840.
105. Wood T.J., Sliva D., Lobie P.E., Gouilleux F., Mui A.L., Groner B., Norstedt G., Haldosen L.A. Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter. Mol. Cell. Endocrinol. 1997, 130:69-81.
106. Xia K., Mukhopadhyay N.K., Inhorn R.C., Barber D.L., Rose P.E., Lee R.S., Narsimhan R.P., D'Andrea A.D., Griffin J.D., Roberts T.M. The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner. Proc. Natl. Acad. Sci. USA 1996, 93:11681-11686.
107. Xing L., Ge C., Zeltser R., Maskevitch G., Mayer B.J., Alexandropoulos K. c-Src signaling induced by the adapters Sin and Cas is mediated by Rap1 GTPase. Mol. Cell. Biol. 2000, 20:7363-7377.
108. Yamauchi T., Kaburagi Y., Ueki K., Tsuji Y., Stark G.R., Kerr I.M., Tsushima T., Akanuma Y., Komuro I., Tobe K., Yazaki Y., Kadowaki T. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase. J. Biol. Chem. 1998, 273:15719-15726.
109. Yamauchi T., Ueki K., Tobe K., Tamemoto H., Sekine N., Wada M., Honjo M., Takahashi M., Takahashi T., Hirai H., Tsushima T., Akanuma Y., Fujita T., Komuro I., Yazaki Y., Kadowaki T. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 1997, 390:91-96.
110. Yi W., Kim S.O., Jiang J., Park S.H., Kraft A.S., Waxman D.J., Frank S.J. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Mol. Endocrinol. 1996, 10:1425-1443.
111. Yin T., Shen R., Feng G.S., Yang Y.C. Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases. J. Biol. Chem. 1997, 272:1032-1037.
112. Zhang Y., Jiang J., Black R.A., Baumann G., Frank S.J. Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: The metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology 2000, 141:4342-4348.
113. Zhu T., Goh E.L., LeRoith D., Lobie P.E. Growth hormone stimulates the formation of a multiprotein signaling complex involving p130(Cas) and CrkII: Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK). J. Biol. Chem. 1998, 273:33864-33875.
114. Zhu T., Goh E.L., Lobie P.E. Growth hormone stimulates the tyrosine phosphorylation and association of p125 focal adhesion kinase (FAK) with JAK2: Fak is not required for Stat-mediated transcription. J. Biol. Chem. 1998, 273:10682-10689.
115. Zhu T., Ling L., Lobie P.E. Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity: GH activation of Ral and phospholipase D is Src-dependent. J. Biol. Chem. 2002, 277:45592-45603.
116. Zhu T., Lobie P.E. Janus kinase 2-dependent activation of p38 mitogen-activated protein kinase by growth hormone: Resultant transcriptional activation of ATF-2 and CHOP, cytoskeletal re-organization and mitogenesis. J. Biol. Chem. 2000, 275:2103-2114.